Pressure Biosciences (OTCMKTS:PBIO) Share Price Passes Above 50 Day Moving Average of $2.91

Pressure Biosciences Inc (OTCMKTS:PBIO) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.91 and traded as high as $2.76. Pressure Biosciences shares last traded at $2.76, with a volume of 110 shares.

Separately, ValuEngine raised Pressure Biosciences from a “hold” rating to a “buy” rating in a research note on Tuesday, July 2nd.

The firm has a 50 day simple moving average of $2.91. The company has a market capitalization of $5.96 million, a price-to-earnings ratio of -0.19 and a beta of 1.13.

Pressure Biosciences (OTCMKTS:PBIO) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($2.01) earnings per share (EPS) for the quarter. The company had revenue of $0.51 million during the quarter.

Pressure Biosciences Company Profile (OTCMKTS:PBIO)

Pressure BioSciences, Inc develops pressure cycling technology (PCT) solutions. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources.

Further Reading: What is a front-end load?

Receive News & Ratings for Pressure Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.